Get startedLog in
    Picture of PharmAbcine logo

    208340 — PharmAbcine Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for PharmAbcine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-30,678-44,033-30,548-14,247-4,924
    Depreciation
    Amortisation
    Non-Cash Items5,5606,7597,9783,600-2,416
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital2,571-3,5883,307-2,334-1,250
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-20,754-39,646-18,181-11,948-7,705
    Capital Expenditures-4,213-1,176-2,006-79.3-7.11
    Purchase of Fixed Assets
    Other Investing Cash Flow Items18,41868,700-4,7579,899-26,251
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities14,20467,524-6,7639,820-26,258
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-890-28,320-1,66235929,907
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-8,473101-24,861-1,464-3,395